Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, MicroRNA in disease regulation, and HER2/EGFR in Cancer Research.
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes
The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
Application of a Fluorescent H <sub>2</sub> S Probe Based on Excited-State Intramolecular Proton Transfer for Detecting Latent Mechanism of H <sub>2</sub> S-induced MCF-7 Apoptosis
QKI is a critical pre-mRNA alternative splicing regulator of cardiac myofibrillogenesis and contractile function
BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy
miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression